
IRadimed Corporation IRMD
$ 96.35
-1.06%
Quarterly report 2025-Q3
added 11-03-2025
IRadimed Corporation Interest Expense 2011-2025 | IRMD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense IRadimed Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 164 K | - | - | - | - | - | - | - | -2.05 K | -3.52 K | 2.72 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 164 K | -3.52 K | 40.4 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.86 | -3.26 % | $ 134 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 307.92 | -1.93 % | $ 8.69 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 45.13 | -2.67 % | $ 6.72 K | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 125.1 | 1.48 % | $ 218 B | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 92.34 | 0.64 % | $ 136 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 2.56 | 8.94 % | $ 95.5 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.7 | -3.46 % | $ 408 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 62.79 | -1.82 % | $ 3.41 B | ||
|
Pulmonx Corporation
LUNG
|
256 K | $ 2.53 | 0.86 % | $ 99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.88 | 0.05 % | $ 709 M | ||
|
Myomo
MYO
|
21.1 K | $ 1.06 | -1.85 % | $ 7.47 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 13.41 | -4.56 % | $ 1.03 B | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 165.15 | 0.78 % | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 1.07 | -3.18 % | $ 110 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 12.81 | -1.23 % | $ 346 M | ||
|
Orthofix Medical
OFIX
|
-9.62 M | $ 15.51 | -1.27 % | $ 591 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 14.86 | -0.03 % | $ 97.4 M | ||
|
AxoGen
AXGN
|
-199 K | $ 30.33 | 1.15 % | $ 1.34 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.78 | 2.33 % | $ 1.26 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.48 | -0.17 % | $ 132 M |